Hutchison China Meditech Limited Director's Share Dealing (3158M)

TIDMHCM

RNS Number : 3158M

Hutchison China Meditech Limited

12 October 2016

Director's Share Dealing

London: Wednesday, October 12, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification that Mr Michael Howell, Independent Non-executive Director, has sold 15,000 ordinary shares of US$1.00 each in Chi-Med (the "Ordinary Shares") at a price of GBP17.90 per share on October 7, 2016.

Following the above transaction, the holding of Mr Howell is 138,600 Ordinary Shares, representing approximately 0.23% of the current issued share capital of Chi-Med.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                                     Mr Michael Howell 
----  -------------------------------------------------------  ------------------------------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Position/status                                          Independent Non-executive Director of Chi-Med 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Initial notification/Amendment                           Initial notification 
----  -------------------------------------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                                     Hutchison China MediTech Limited 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    LEI                                                      N/A 
----  -------------------------------------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Description of the financial instrument, type of         Ordinary Shares of US$1.00 each 
        instrument                                                DI ISIN: KYG4672N1016 
        Identification code                                       ADS ISIN: US44842L1035 
----  -------------------------------------------------------  ------------------------------------------------------- 
  b)    Nature of the transaction                                Sale of 15,000 Ordinary Shares on October 7, 2016 at 
                                                                 a price of GBP17.90 
----  -------------------------------------------------------  ------------------------------------------------------- 
  c)    Price(s) and volume(s)                                    Price(s)    Volume(s) 
                                                                  ----------  ---------- 
                                                                   GBP17.90     15,000 
                                                                  ----------  ---------- 
----  -------------------------------------------------------  ------------------------------------------------------- 
  d)    Aggregated information                                   N/A 
         -  Aggregated volume 
         -  Price 
----  -------------------------------------------------------  ------------------------------------------------------- 
  e)    Date of the transaction                                  2016-10-07 
----  -------------------------------------------------------  ------------------------------------------------------- 
  f)    Place of the transaction                                 London Stock Exchange (XLON) 
----  -------------------------------------------------------  ------------------------------------------------------- 
 

NOTES TO EDITORS

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001). For more information, please visit: www.chi-med.com.

Contacts

 
Investor Enquiries 
Christian Hogg, CEO               [phone] 
 
International Media Enquiries 
Anthony Carlisle,                 [phone] (Mobile)   [e-mail] 
 Citigate Dewe Rogerson 
 
U.S. Based Media Enquiries 
Brad Miles, BMC Communications    [phone] (Mobile)  [e-mail] 
 
Susan Duffy, BMC Communications   [phone] (Mobile)  [e-mail] 
 
Investor Relations 
Matt Beck, The Trout Group        [phone] (Mobile)    [e-mail] 
 
David Dible,                      [phone] (Mobile)   [e-mail] 
 Citigate Dewe Rogerson 
 
Panmure Gordon (UK) Limited 
Richard Gray / Andrew Potts       [phone] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFSEIVLFLIR

(END) Dow Jones Newswires

October 12, 2016 02:00 ET (06:00 GMT)